Six HIMSS EMRAM Stage 6 Hospitals Awarded at HIMSS Turkey Educational Conference & Exhibition

HIMSS Europe20 - 21 March 2015, Antalya, Turkey.
Six Turkish hospitals will be awarded the prestigious Stage 6 EMRAM award for demonstrating outstanding levels of IT implementation ensuring superior healthcare services and much increased patient safety.

The awards will be presented at the second HIMSS Turkey Educational Conference & Exhibition, which opens its doors in Antalya. The conference, a joint initiative between the Turkish Ministry of Health and HIMSS Europe, is the second in a series of five conferences. The conferences will showcase the results of the Turkish EMRAM data collection, which HIMSS is collecting on behalf of the Turkish Ministry of Health to have all 850 public Turkish Hospitals in the HIMSS Analytics database by 2019.

The six HIMSS EMRAM (EMR Adoption Model) Stage 6 hospitals to be awarded are:

  • Tirebolu Devlet Hastanesi, Giresun.
  • Dr. Suat Seren Göğüs Hastalıkları ve Cerrahisi Eğitim ve Araştırma Hastanesi, İzmir
  • Meslek Hastalıkları Hastanesi, Ankara
  • Bandırma Devlet Hastanesi, Balıkesir
  • Fizik Tedavi ve Rehabilitasyon Hastanesi, Bolu
  • Katip Çelebi Üniversitesi Atatürk Eğitim ve Araştırma Hastanesi, İzmir

Dr. Yilmaz Salman, Head Doctor, from Tirebolu Devlet Hastanesi, one of the hospitals that has reached Stage 6 said: "Our IT systems are helping us to coordinate much of our work and keep track of our patient medical and financial information and coordinate between our departments, with HIMSS EMRAM stage 6 we are able to put new goals such as medical decision support system usage in our system. We will continue working to demonstrate a more elaborated system and HIMSS stage 6 acknowledgments which will encourage us even to do more."

The HIMSS Turkey conference takes place March 20 & 21, 2015 at the Titanic Deluxe Belek Hotel in Antalya. The main themes of the conference are public private partnership projects, healthcare IT and mobility, standards in interoperability, patient involvement, personlised medicine and genomics.

H. Stephen Lieber, President and CEO of HIMSS, said: "Turkey is fast becoming a leading figure in Europe in the transformation of health care through information technology. With six new Stage 6 hospitals recognised this year and five identified last year, Turkey now has 11 'flagship' hospitals in terms of EMR adoption. In absolute numbers Turkey now has the third highest share of Stage 6/7 hospitals in Europe trailing only Spain and the Netherlands. This average and the high number of Stage 6 Award recipients brings Turkey in a league with the top EMRAM countries in Europe. I am proud to celebrate this great accomplishment with those who have driven the country to this strong leadership position."

For further information, please visit:
http://www.himssturkey.org

About HIMSS
HIMSS is a global, cause-based, not-for-profit organization focused on better health through information technology (IT). HIMSS leads efforts to optimize health engagements and care outcomes using information technology.

HIMSS is a part of HIMSS WorldWide, a cause-based, global enterprise producing health IT thought leadership, education, events, market research and media services around the world. Founded in 1961, HIMSS WorldWide encompasses more than 52,000 individuals, of which more than two-thirds work in healthcare provider, governmental and not-for-profit organizations across the globe, plus over 600 corporations and 250 not-for-profit partner organizations, that share this cause. HIMSS WorldWide, headquartered in Chicago, serves the global health IT community with additional offices in the United States, Europe, and Asia.

Most Popular Now

Bayer and Google Cloud to Accelerate Dev…

Bayer and Google Cloud announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve patients. As part of the collaboration, Bayer will...

SPARK TSL Acquires Sentean Group

SPARK TSL is acquiring Sentean Group, a Dutch company with a complementary background in hospital entertainment and communication, and bringing its Fusion Bedside platform for clinical and patient apps to...

Can AI Techniques Help Clinicians Assess…

Investigators have applied artificial intelligence (AI) techniques to gait analyses and medical records data to provide insights about individuals with leg fractures and aspects of their recovery. The study, published in...

AI Makes Retinal Imaging 100 Times Faste…

Researchers at the National Institutes of Health applied artificial intelligence (AI) to a technique that produces high-resolution images of cells in the eye. They report that with AI, imaging is...

Standing Up for Health Tech and SMEs: Sh…

AS the new chair of the health and social care council at techUK, Shane Tickell talked to Highland Marketing about his determination to support small and innovative companies, by having...

GPT-4 Matches Radiologists in Detecting …

Large language model GPT-4 matched the performance of radiologists in detecting errors in radiology reports, according to research published in Radiology, a journal of the Radiological Society of North America...

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Experts Propose Specific and Suited Guid…

Current Artificial Intelligence (AI) models for cancer treatment are trained and approved only for specific intended purposes. GMAI models, in contrast, can handle a wide range of medical data including...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...